from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3246c/mtrA

LFCtreatmentdescriptionclass of inhibitor

1.171

Amikacinug/mL Amikacintranslation

0.643

Cap5-10ug/mL Capreomycintranslation

0.355

Rox10-50 ug/mL Roxithromycintranslation

-0.204

SM2-5 ug/mL Streptomycintranslation

2.595

Tet5-10 ug/mL Tetracyclinetranslation

-0.207

Rif0.2-5ug/mL Rifampicintranscription

-0.728

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.306

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.723

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.367

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.481

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.727

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.408

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.256

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.349

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.697

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.630

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.727

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.615

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.769

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.025

KCN5-20 ug/mL Potassium cyaniderespiration

0.217

NaN30.2-2 mM Sodium aziderespiration

-0.469

Nigericin50 uM Nigericinrespiration

1.587

TRC10-150 ug/mL Triclosanrespiration

-0.323

TRZ10-25 ug/mL Thioridazinerespiration

-1.717

Valinomycin0.5-10 uM Valinomycinrespiration

-0.506

ZnSO42 mM ZnSO4respiration

-1.036

menadione6-10 ug/mL Menadionerespiration

-0.883

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.013

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.353

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.226

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.660

NRP_1Non-replicating persistence stage 1dosRassociated

0.524

Amp0.2mg/mL AmpicillincellWall

1.067

Cephalexin20-100 ug/mL CephalexincellWall

-0.261

Cerulenin0.32-5 ug/mL CerulenincellWall

0.100

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.188

EMB10-20 ug/mL EthambutolcellWall

0.627

Eta12-40 ug/mL EthionamidecellWall

1.249

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.498

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.406

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.293

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.213

BZA0.12 mg/mL BenzamidearomaticAmides

1.336

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.892

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.142

H2O24 mM hydrogen peroxideDNAdamaging

0.334

Levo10 ug/mL LevofloxacinDNAdamaging

-0.224

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.453

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.250

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.045

UVUV-irradiationDNAdamaging

-1.944

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.800

Antimycin12.5-50 ug/mL Antimycin A?

0.274

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.145

PA_110-50 ug/mL Antitubercular compound PA-1?

0.064

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.199

PA8240.2-2 ug/mL PA-824?

0.544

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.124

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.508

Verapamil50 uM Verapamil?

0.054

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.333

methoxatin10-20 ug/mL Methoxatin?